In his weekly clinical update Dr. Griffin\xa0discusses the efficacy and safety of two RSV vaccines in older adults, health care vaccine mandate remains as some push for an end, past SARS-CoV-2 infection protection against re-infection, a third vaccine dose equalizes the levels of effectiveness and immunogenicity of heterologous or homologous COVID-19 vaccine regimens, Sotrovimab retains activity against SARS-CoV-2 Omicron variant BQ.1.1 in a non-human primate model, effect of higher-dose Ivermectin for 6 Days vs placebo on time to sustained recovery in outpatients with COVID-19, viral burden rebound in hospitalized patients with COVID-19 receiving oral antivirals in Hong Kong, serological response to vaccination in post-acute sequelae of COVID, sex differences in cardiovascular complications and mortality in hospital patients with COVID-19, association of COVID-19 vaccination with risk for incident diabetes after COVID-19, postacute sequelae of SARS-CoV-2 in university setting, the CDC\u2019s long-Covid deception, and podcast companies, once walking on air, feel the strain of gravity.
Subscribe (free): Apple Podcasts,\xa0Google Podcasts,\xa0RSS,\xa0emailBecome a\xa0patron\xa0of\xa0TWiV!
Links for this episodeIntro music is by\xa0Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv